Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice

By Moreno C.A.   Rodriguez R.   Oliveira G.A.   Ferreira V.   Nussenzweig R.S.   Moya Castro Z.R.   Calvo-Calle J.M.   Nardin E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein

By Ioannou X.P.   Gomis S.M.   Karvonen B.   Hecker R.   Babiuk L.A.   van Drunen Littel-van den Hurk S.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 127-137

Elsevier

Access to resources Recommend Favorite

Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

By Lingnau K.   Egyed A.   Schellack C.   Mattner F.   Buschle M.   Schmidt W.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3498-3508

Elsevier

Access to resources Recommend Favorite

CpG motifs as immune adjuvants

By Klinman D.M.   Barnhart K.M.   Conover J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Malaria DNA vaccines in Aotus monkeys

By Gramzinski R.A.   Maris D.C.   Doolan D.   Charoenvit Y.   Obaldia N.   Rossan R.   Sedegah M.   Wang R.   Hobart P.   Margalith M.   Hoffman S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 913-915

Elsevier

Access to resources Recommend Favorite